RRX

RRX Operating Cash Flow (Statement)

$556.90MTTM · USD

Period ending:

RRX FY Cash from OperationsUSD
RRX FY Cash from Operations1989-12-31: $20.40M1990-12-31: $18.00M1991-12-31: $20.10M1992-12-31: $22.60M1993-12-31: $24.40M1994-12-31: $27.60M1995-12-31: $35.70M1996-12-31: $53.70M1997-12-31: $78.80M1998-12-31: $50.40M1999-12-31: $70.30M2000-12-31: $52.09M2001-12-31: $81.77M2002-12-31: $54.41M2003-12-31: $58.97M2004-12-31: $38.16M2005-12-31: $112.21M2006-12-31: $93.55M2007-12-31: $200.63M2008-12-31: $154.20M2009-12-31: $314.92M2010-12-31: $175.39M2011-12-31: $265.30M2012-12-31: $351.70M2013-12-31: $305.00M2014-12-31: $298.20M2015-12-31: $381.10M2016-12-31: $439.60M2017-12-31: $291.90M2018-12-31: $362.70M2019-12-31: $408.50M2020-12-31: $435.40M2021-12-31: $357.70M2022-12-31: $436.20M2023-12-31: $715.30M2024-12-31: $609.40M2025-12-31: $990.80M$990.80M$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RRX operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Regal Rexnord Corporation Common Stock Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
990,800,000
609,400,000
715,300,000
436,200,000
357,700,000
435,400,000
408,500,000
362,700,000
291,900,000
439,600,000
381,100,000
298,200,000
305,000,000
351,700,000
265,296,000
175,388,000
314,919,000
154,199,000
200,626,000
93,548,000
112,211,000
38,164,000
58,965,000
54,409,000
81,769,000
52,089,000
70,300,000
50,400,000
78,800,000
53,700,000
35,700,000
27,600,000
24,400,000
22,600,000
20,100,000
18,000,000
20,400,000

Compare operating cash flow (statement)

All RRX financial metrics · RRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.